Gilead Fights High Court Bid Over 'Possession' Of Invention
Gilead's Kite Pharma Inc. says the U.S. Supreme Court shouldn't review a Federal Circuit decision that erased a Bristol-Myers Squibb unit's $1.1 billion victory in a cancer therapy case, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article